ePartogram Effectiveness Study in Kenya

Status Completed

Clinical Trial Summary

Quasi-experimental study to evaluate whether clinical care offered to clients was more appropriate and in line with WHO recommendations for care in normally progressing labor and in labor with complications, among providers using the novel intervention, ePartogram (an electronic version of the WHO paper partograph) vs. providers who offered care using the standard paper partograph, and whether fetal/newborn outcomes were improved among cases where partograph was used.

Clinical Trial Description

The ePartogram is an electronic version of the WHO Partograph and is developed by Jhpiego. Seventy-eight clinical rules, programmed into the ePartogram, are based on global guidelines in the WHO manual "Managing complications in pregnancy and childbirth: a guide for midwives and doctors" and the expert opinion of Jhpiego physicians and nurse-midwives. The rules underwent a validation process by 65 expert skilled birth attendants (SBAs) (working in maternity wards of health facilities) from a variety of geographic and clinical settings affiliated with Jhpiego. In the ePartogram application ("app") that is put on an Android tablet computer, the clinical rules trigger "reminders" to SBAs to take a routine clinical measurement, such as fetal heart rate (every 30 minutes) or maternal temperature (every 2 hours). The rules also trigger "low-level" alarms indicating a measurement that falls in the abnormal range that could be cause for concern (i.e. meconium-stained liquor), and "high-level" alarms that could indicate need for immediate action (i.e. maternal systolic blood pressure ≥160 mm Hg).

Litwin et al. reported on the feasibility and acceptability of use of an electronic partogram in Zanzibar and concluded that health workers felt the ePartogram improved timeliness of care and supported decision making. Health workers quickly became competent and confident in using the tablet device and ePartogram application. This study in Kenya has an objective to evaluate whether providers' use of the ePartogram improves labor outcomes and labor management in health facilities. The study design is a quasi-experimental design evaluation comparing data collected at 6 intervention sites and 6 comparison sites with similar facility characteristics and in two regions of Kenya. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03757598
Study type	Interventional
Source	Jhpiego
Contact
Status	Completed
Phase	N/A
Start date	August 1, 2016
Completion date	May 30, 2017

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04070066` - Educational Strategy IN Exchange Transfusion	N/A
Recruiting	`NCT04405700` - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Completed	`NCT04258722` - Reducing Adverse Delivery Outcomes Through Teleneonatology: A Feasibility Study	N/A
Recruiting	`NCT05728307` - Post-market Observation of a Wireless Vital Sign Monitor for Hospitalized Newborns in Kenya
Completed	`NCT01346813` - Epidemiology of Painful Procedures in Neonates	N/A
Active, not recruiting	`NCT04054453` - Prevention of Epilepsy by Reducing Neonatal Encephalopathy	N/A
Active, not recruiting	`NCT04184544` - Scaling up Evidence Based MNCH Interventions : A Quasi Experimental Study Umeed e Nau (UeN) Project	N/A
Recruiting	`NCT06256406` - Effects of Confortable Environment, Kangaroo Care and Music Therapy in Newborns in Neonatal Intensive Care Unit	N/A
Completed	`NCT04925908` - Exclusive Breastfeeding in Infants of Mothers Infected With Novel Coronavirus
Recruiting	`NCT03235635` - Metagenomic Analysis of Gut Microbiome in Preterm	N/A
Completed	`NCT04323397` - Nasal HFOV Versus Nasal SIPPV in Neonate Following Extubation: RCT Crossover Study	N/A
Completed	`NCT04422041` - Comparison of Early Versus Very Early Postnatal Discharge on Hospital Readmissions in Newborns	N/A
Completed	`NCT02643472` - GPS (Giving Parents Support): Parent Navigation After NICU Discharge	N/A
Recruiting	`NCT06081075` - Newborn Genomics Programme
Recruiting	`NCT05639309` - Liver Regional Oxygen Saturation in Preterm Patent Ductus Arteriosus
Completed	`NCT03350022` - Sham Feeding Post-operative Infants	N/A
Recruiting	`NCT06170892` - Kangaroo Position in Preterm Newborn Infants Under Oxygen Therapy	N/A
Completed	`NCT06130488` - Implementation at Scale and Evaluation of KMC	N/A
Not yet recruiting	`NCT03786497` - Protecting Brains and Saving Futures - the PBSF Protocol
Completed	`NCT04191239` - Comparing Two Different Modes of Ventilation in Pretem Neonates Bilevel VG and PRVC

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.